CRISPR-Edited Stem Cells in a Patient with HIV and Acute Lymphocytic Leukemia

CRISPR–Cas9 (clustered regularly interspaced short palindromic repeats [CRISPR]–CRISPR-associated protein 9 [Cas9]) technology has been widely applied to edit the genome of mammalian cells in vitro. Although this approach shows potential clinical usefulness and clinical trials have been initiated…

Leave a Reply

Your email address will not be published. Required fields are marked *